3.29

6.53% -0.23

After Hours: 3.34 0.05 +1.52%

Canton Strategic Holdings Inc (CNTN)

Overview News Price History Discussions Forecast

Canton Strategic Holdings Inc stock is traded at $3.29, with a volume of 381.43K. It is down -6.53% in the last 24 hours and down -3.52% over the past month. Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Previous Close:

$3.52

Open:

$3.52

24h Volume:

381.43K

Relative Volume:

0.67

Market Cap:

$229.66M

Revenue:

Net Income/Loss:

$-35.92M

P/E Ratio:

-1.1911

EPS:

-2.7622

Net Cash Flow:

$-16.13M

1W Performance:

+0.77%

1M Performance:

-3.52%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$3.28

$3.5941

1-Week Range:

$3.17

$3.6499

52-Week Range:

$2.89

$5.265

Canton Strategic Holdings Inc Stock (CNTN) Company Profile

Name

Canton Strategic Holdings Inc

Sector

Healthcare (1111)

Industry

Biotechnology (621)

Phone

302-743-2995

Address

1200 ROUTE 22 EAST, BRIDGEWATER

Employee

Twitter

Next Earnings Date

2026-05-11

Latest SEC Filings

CNTN's Discussions on Twitter

Compare CNTN vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CNTN Canton Strategic Holdings Inc	3.29	245.71M	0	-35.92M	-16.13M	-2.7622
VRTX Vertex Pharmaceuticals Inc	435.93	110.28B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	634.62	66.98B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	808.43	50.15B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	295.50	39.71B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	154.89	32.22B	742.00K	-1.37B	-1.07B	-7.0731

Canton Strategic Holdings Inc Stock (CNTN) Latest News

May 22, 2026

CNTN Should I Buy - Intellectia AI

May 22, 2026

CNTN Q4 2023 Earnings: Narrower-Than-Expected Loss Drives Share UptickEarnings Quality Analysis - Newser

May 22, 2026

May 19, 2026

Canton Strategic Holdings, Inc.Common Stock (Nasdaq:CNTN) Stock Quote - The Chronicle-Journal

May 19, 2026

CNTN Stock Price, Quote & Chart | CANTON STRATEGIC HOLDINGS IN (NASDAQ:CNTN) - ChartMill

May 19, 2026

Canton Strategic (NASDAQ:CNTN) Growth Story Draws Market Attention - Kalkine Media

May 15, 2026

We're Not Very Worried About Canton Strategic Holdings' (NASDAQ:CNTN) Cash Burn Rate - Yahoo Finance

May 15, 2026

May 13, 2026

Canton Strategic Holdings Releases Q1 2026 Financial Results - AlphaStreet

May 13, 2026

ExlService Holdings Drops 5.3% Amid Sector-Wide Selling - AlphaStreet

May 13, 2026

Canton Strategic Holdings, Inc. Quarterly Report (Form 10-Q) Highlights Financials, Digital Asset Strategy, and Market Risks - Minichart

May 13, 2026

Canton Strategic Holdings, Inc. 1Q 2026: Net loss $(47.3M), EPS $(0.23) — 10-Q Summary - TradingView

May 13, 2026

Canton Strategic Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 13, 2026

Canton Strategic Holdings Q1 net loss widens on higher expenses - TradingView

May 13, 2026

Canton Strategic Holdings Reports First Quarter 2026 Financial and Operational Results - marketscreener.com

May 13, 2026

Press Release: Canton Strategic Holdings Reports First Quarter 2026 Financial and Operational Results - Moomoo

May 13, 2026

May 12, 2026

Number of shareholders of Canton Strategic Holdings, Inc. – NASDAQ:CNTN - TradingView

May 12, 2026

May 11, 2026

What Canton (CNTN) disclosed about cost pressures | Q4 2023: EPS Exceeds ExpectationsCrowd Sentiment Stocks - Newser

May 11, 2026

May 10, 2026

Dividend HistoryCanton Strategic Holdings, Inc. (CNTN) - Zacks Investment Research

May 10, 2026

May 08, 2026

CNTN (Canton) Q4 earnings surprise, 44% beats estimates despite zero revenue; stock rises 1.34%.Community Watchlist Picks - Newser

May 08, 2026

The sustainable advantages Canton (CNTN) is developing (Nudges Up) 2026-05-08Trend Signals - Newser

May 08, 2026

May 07, 2026

21Shares Canton Network's first U.S. ETF, 'TCAN,' launches on Nasdaq (CNTN:NASDAQ) - Seeking Alpha

May 07, 2026

Apr 29, 2026

Canton Strategic Holdings (CNTN) Registration Filing Summary - Quartr

Apr 29, 2026

Apr 26, 2026

Canton Strategic Holdings (CNTN) Proxy Filing Summary - Quartr

Apr 26, 2026

Canton Strategic Holdings (CNTN) EGM 2026 Summary - Quartr

Apr 26, 2026

Canton Strategic Holdings (CNTN) Q4 2025 earnings summary - Quartr

Apr 26, 2026

Apr 25, 2026

Tharimmune Highlights Canton Network Q1 Growth, Tokenomics Shift and Validator Locking in Webinar - MarketBeat

Apr 25, 2026

Apr 22, 2026

CNTN: Institutional adoption, protocol upgrades, and tokenomics reforms drive ecosystem growth - TradingView

Apr 22, 2026

CNTN: Transaction volume surged, tokenomics shifted to apps, and institutional adoption accelerated - TradingView

Apr 22, 2026

Apr 20, 2026

Canton Strategic Holdings, Inc. Presents Quarterly Canton Network Ecosystem Update - 富途牛牛

Apr 20, 2026

Apr 19, 2026

Canton Strategic Holdings Company Profile & Introduction - Moomoo

Apr 19, 2026

Apr 14, 2026